All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
Now you can personalise
your Lupus Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for youFind out more
Bookmark this article
Lupus nephritis (LN) is a common issue that patients with systemic lupus erythematosus (SLE) develop, with up to 60% of patients developing this sequela.1 For patients with SLE, LN development is associated with a significant level of morbidity and mortality; therefore, there is an urgent need to identify treatment combinations that combat this.1
A recent publication by Zheng et al.1 in Rheumatology investigated the effect of tacrolimus against intravenous cyclophosphamide in Chinese patients with LN. The Lupus Hub is happy to provide a visual abstract summarizing the data from this study.
To download this visual abstract, click below.Download here
Management of general systemic lupus erythematosus
This article summarizes the 2019 recommendations for the management of SLE, along with recent developments from subsequent clinical trials.
Management of lupus nephritis
In their article published in Nephrology, Dialysis, Transplantation late in 2021, Anders et al., of ERA, sought to identify and clarify the differences between two guidelines. We will summarize this publication, along...
Subscribe to get the best content related to lupus delivered to your inbox